Ebos targeting pharmacy revenue growth, acquisition opportunities
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
Mitre 10 starts banking IT project gains
The hardware store chain has gained share in a tough market.
On the Money: The EU, Air NZ succession, and more
A royal succession plays out in the skies, and Luxon talks about toast.
Budapest bust shows pressure works on Putin
Rattling Russia’s cage some more might bring Putin to his senses.
NZ risks losing edge as Australia takes lead in cleaner jet fuel
Experts warn SAF delay could cost jobs and growth.
